Voices
Rebecca Shatsky: Scalp Cooling Shows No Benefit in Hair Preservation During T-DXd Therapy
Rebecca Shatsky/X

Rebecca Shatsky: Scalp Cooling Shows No Benefit in Hair Preservation During T-DXd Therapy

ESMO Open shared a post onX:

”Scalp cooling outcomes in patients receiving trastuzumab deruxtecan for metastatic breast cancer in ESMO Open.

No benefit of scalp cooling in terms of hair preservation or quality of life.

G2 alopecia primary reason for scalp cooling discontinuation.”

Rebecca Shatsky, Breast Cancer Medical Oncology Team Leader at UCSD, shared ESMO Open’s post, adding:

”Very important finding. No benefit to scalp cooling with T’DxD.”

Title: Scalp cooling outcomes in patients receiving trastuzumab deruxtecan for metastatic breast cancer

Authors: E. Salehi, X. Chu, E. L. Mayer, S. Singer, G. Augdahl, M. Stalteri, T. Li, K. E. Dibble, N. Sinclair, M. Faggen, J. Walsh, S. Sammons, K. Sendrick, S. Hanna, A. Mostaghimi, N. Tayob, N. R. LeBoeuf, S. M. Tolaney

Read The Full Article.

Rebecca Shatsky: Scalp Cooling Shows No Benefit in Hair Preservation During T-DXd Therapy

Breast Cancer Research Highlights: Key Publications From May 29 To June 5, 2026
Rebecca Shatsky: Scalp Cooling Shows No Benefit in Hair Preservation During T-DXd Therapy

A. Mostaghimi Breast Cancer cancer E. Salehi E.L. Mayer ESMO Open G. Augdahl J. Walsh K. E. Dibble K. Sendrick M. Faggen M. Stalteri N. R. LeBoeuf N. Sinclair N. Tayob OncoDaily Oncology Rebecca Shatsky S. Hanna S. Sammons S. Singer S.M. Tolaney T. Li X. Chu